SCHEMBL1347032

SCHEMBL1347032

COc1ccc(C2Cc3ccc(OC)cc3C(Cc3ccc(F)cc3)C2C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CYP19A1 P11511 1/20 0.37
CYP26A1 O43174 1/20 0.37
OPRM1 P35372 2/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
MAOB P27338 3/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
SLC10A2 Q12908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14655844 0.94 NQO2 (0.43) NQO2MTNR1AMTNR1BCYP19A1CYP26A1
SCHEMBL1346063 0.88 NQO2 (0.48) NQO2MTNR1AMTNR1BCYP19A1MAOB
SCHEMBL1344502 0.88 NQO2 (0.43) NQO2MTNR1AMTNR1BMAPTCA1
SCHEMBL12133264 0.88 NQO2 (0.42) NQO2MTNR1AMTNR1BMAPTCA1
SCHEMBL1344496 0.86 NQO2 (0.41) NQO2MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL1344331 0.83 NQO2 (0.44) NQO2MTNR1AMTNR1BL3MBTL1OPRM1
SCHEMBL1346637 0.82 NQO2 (0.46) NQO2MTNR1AMTNR1BMAPTOPRM1
SCHEMBL1344609 0.81 SHBG (0.43) CYP26A1OPRM1OPRD1OPRK1MAOB
SCHEMBL1346531 0.81 SHBG (0.43) CYP26A1OPRM1OPRD1OPRK1MAOB
SCHEMBL1346151 0.81 SHBG (0.43) CYP26A1OPRM1OPRD1OPRK1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406206-B1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD OSS BV (NL) 2013-01-30 EP disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES VHL, BRCA1, TPH2 NQO2 1888/4885MTNR1A 133/4885MTNR1B 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.